Limb‑bud and heart as a novel biomarker for gastric intestinal type adenocarcinoma

Shusheng Wu(University of Science and Technology of China), Yifu He(Anhui Provincial Hospital), Huiqin Luo(University of Science and Technology of China), Ying Yan(East China University of Science and Technology), Wen‐Ju Chen(University of Science and Technology of China), Jian Chen(University of Science and Technology of China)
Oncology Letters
June 25, 2020
10.3892/ol.2020.11778
Cited by 4

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
|JAMA|2023|384
Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer
|Genome biology|2020|242
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
|癌症：英文版|2021|207
Caffeoylquinic acid derivatives isolated from the aerial parts of Gynura divaricata and their yeast α-glucosidase and PTP1B inhibitory activity
|Fitoterapia|2014|124